Pricing Log in Create free account
Friday 6 November 2026 Export RGEN’s income statement to Excel — free account

Repligen Corporation

RGEN Healthcare Medical Instruments & Supplies

Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024.

Revenue
+10.9%
EPS
−351.9%
Free cash flow
−11.5%
Total debt
+3.28%

Quarter to September 2026, against a year earlier

169.01 9.19 −5.16%
Market cap
$10.8B
P/E
0.0×
Fwd P/E
−615×
Dividend yield
—
F-score
6/9
Altman Z
7.49
Beneish M
−2.52
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Repligen Corporation (RGEN) SEC filings, changes and red flags

Red flags

  • Material weakness

    Repligen Corporation’s 10-Q reports a material weakness in internal control over financial reporting

    Except for the material weaknesses described above, there have been no changes in our internal control over financial reporting

    10-Q filed · The filing · sec.gov

  • Share dilution

    Shares outstanding rose 13.6% in a year, to 63.9 million

    10-Q filed · The filing · sec.gov

  • Officer departure

    Repligen Corporation reported the departure of its Chief Executive Officer

    8-K filed · The filing · sec.gov

  • Restatement

    Repligen Corporation’s 10-K corrects an error in previously issued financial statements

    10-K filed · The filing · sec.gov

Filings

Form Period Filed What it reports Flags
10-Q Sep 30, 2026 P1I2: 6 added · 6 removed · 24 modified
P2I1A: 2 removed · 3 modified 		Material weakness Share dilution
8-K Oct 29, 2026 3.02 Unregistered sales of equity securities; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Oct 27, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 6, 2026 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Sep 10, 2026 5.02 Departure or appointment of directors or officers Officer departure
8-K Sep 3, 2026 8.01 Other events
10-Q Jun 30, 2026
8-K Jul 28, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 21, 2026 1.01 Entry into a material definitive agreement; 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K May 14, 2026 5.07 Submission of matters to a vote of security holders
10-Q Mar 31, 2026
8-K May 5, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 20 added · 56 removed · 52 modified
1A: 33 added · 23 removed · 55 modified
7: 21 added · 34 removed · 42 modified
8-K Feb 24, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 6, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Oct 28, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 1, 2025 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
8-K Jul 29, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K Apr 29, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024 Restatement
8-K Feb 20, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Nov 12, 2024 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Sep 12, 2024 2.02 Results of operations and financial condition; 4.02 Non-reliance on previously issued financial statements; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Jul 30, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 1, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 21, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.